09 July 2001 00:00 [Source: ICB Americas]IVAX has completed its acquisition of Laboratorio Chile S.A., the largest Chilean pharmaceutical company in terms of sales.
NERAMEXANE Forest Laboratories Inc. will develop and market neramexane, a patented novel NMDA receptor antagonist developed by Merz and Co. of Germany, in the US. NMDA receptors mediate a variety of neurological functions. Neramexane will enter into Phase II trials for a broad range of indications.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Asian Chemical Connections